For example, studies evaluating the efficacy of tripterygium glycosides (GTW) as an adjuvant therapeutic agent (anti-cancer agent) in chemo-resistant A2780/DPP epithelial ovarian cancer (EOC) cells, together with cisplatin (DPP), showed an association between activation of ILK signaling, EMT and chemoresistance [58]. The gene discussed is ILK; the disease is ovarian carcinoma.